SHG:603439 - Guizhou Sanli Pharmaceutical Co Ltd

Guizhou Sanli Pharmaceutical C
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance (Live Price)

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2018 Q2	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	247.82M 91.9%	237.4M -4.2%	324.59M 36.7%	158.68M -51.1%	271.11M 70.9%	280.35M 3.4%	491.18M 75.2%	348.98M -29.0%	281.68M -19.3%	338.84M 20.3%	665.47M 96.4%	422.02M -36.6%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	72.34M 81.0%	66.74M -7.7%	97.96M 46.8%	46.8M -52.2%	82.95M 77.3%	78.08M -5.9%	131.67M 68.6%	96.31M -26.9%	77.28M -19.8%	82.66M 7.0%	180.06M 117.8%	128.68M -28.5%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	175.48M 96.7%	170.65M -2.8%	226.63M 32.8%	111.88M -50.6%	188.16M 68.2%	202.27M 7.5%	359.51M 77.7%	252.67M -29.7%	204.4M -19.1%	256.18M 25.3%	485.42M 89.5%	293.35M -39.6%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	194.36M 71.8%	193.48M -0.5%	274.99M 42.1%	141.44M -48.6%	225.69M 59.6%	236.13M 4.6%	374.05M 58.4%	287.45M -23.2%	233.53M -18.8%	274.37M 17.5%	557.25M 103.1%	347.78M -37.6%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	122.02M 66.8%	126.73M 3.9%	177.04M 39.7%	94.65M -46.5%	142.74M 50.8%	158.05M 10.7%	242.38M 53.4%	191.14M -21.1%	156.25M -18.3%	191.71M 22.7%	377.19M 96.8%	219.11M -41.9%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	53.46M 233.2%	43.92M -17.9%	49.6M 12.9%	17.24M -65.2%	45.42M 163.5%	44.22M -2.6%	117.13M 164.9%	61.52M -47.5%	48.15M -21.7%	64.48M 33.9%	108.23M 67.9%	74.24M -31.4%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	69.39M -	-	-	-	59.45M -	-	-	-	100.19M -	-	-	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	45.95M 96.0%	42.54M -7.4%	40.36M -5.1%	23.73M -41.2%	40.26M 69.7%	39.65M -1.5%	97.64M 146.3%	54.93M -43.7%	46.01M -16.2%	57.02M 23.9%	134.74M 136.3%	56.05M -58.4%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.11 83.3%	0.1 -9.1%	0.1 0%	0.06 -40.0%	0.1 66.7%	0.09 -10.0%	0.24 166.7%	0.13 -45.8%	0.12 -7.7%	0.14 16.7%	0.32 128.6%	0.14 -56.3%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.11 83.3%	0.1 -9.1%	0.1 0%	0.06 -40.0%	0.1 66.7%	0.09 -10.0%	0.24 166.7%	0.13 -45.8%	0.12 -7.7%	0.14 16.7%	0.32 128.6%	0.14 -56.3%